InvestorsHub Logo
Followers 138
Posts 22869
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Friday, 09/16/2016 11:36:23 PM

Friday, September 16, 2016 11:36:23 PM

Post# of 344
An attractive alternative to Celgene’s OTEZLA

We believe that the potential safety profile of Prurisol may make this an attractive alternative to Celgene’s OTEZLA, which is on its way to achieving $1 billion in sales within just three years of its launch.”




http://cellceutix.com/cellceutix-corporation-provides-business-update-and-timeline-of-upcoming-milestones/#sthash.ocS8l7pM.dpuf

http://cellceutix.com/wp-content/uploads/2014/06/Cellceutix_Corporate_Slide-Deck_DERMATOLOGY-Non-Confidential-July-2016-1-1.pdf


Good luck and GOD bless,

George